We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Harley-Davidson
HOG
$2.78B
| $553K | ﹤0.01% |
13,551
-64,883
| -83% | -$2.76M |
|
1777
Onto Innovation
ONTO
$15.7B
| $552K | ﹤0.01% |
8,112
-8,181
| -50% | -$588K |
|
1778
Gogo Inc
GOGO
$390M
| $551K | ﹤0.01% |
37,325
+1,863
| +5% | +$26.9K |
|
1779
ZipRecruiter
ZIP
$405M
| $550K | ﹤0.01% |
33,496
-1,387
| -4% | -$23K |
|
|
B
1780
Barrick Mining
B
$67.2B
| $549K | ﹤0.01% |
31,959
-4,408
| -12% | -$70.1K |
|
1781
Vaxcyte
PCVX
$8.8B
| $548K | ﹤0.01% |
11,437
+2,111
| +23% | +$82.8K |
|
1782
Sunrun
RUN
$2.41B
| $548K | ﹤0.01% |
23,221
-25,377
| -52% | -$677K |
|
1783
Madrigal Pharmaceuticals
MDGL
$12.4B
| $547K | ﹤0.01% |
+1,885
| New | +$184K |
|
1784
Herc Holdings
HRI
$5.72B
| $543K | ﹤0.01% |
4,129
-1,819
| -31% | -$223K |
|
1785
NWPX Infrastructure Inc
NWPX
$1.08B
| $543K | ﹤0.01% |
+16,120
| New | +$547K |
|
1786
Clover Health Investments
CLOV
$2.33B
| $542K | ﹤0.01% |
+583,466
| New | +$779K |
|
1787
Cosan
CSAN
$2.53B
| $541K | ﹤0.01% |
41,434
+17,929
| +76% | +$231K |
|
1788
Digital Turbine
APPS
$1.58B
| $539K | ﹤0.01% |
35,345
-458,566
| -93% | -$7.05M |
|
1789
Central Garden & Pet Co Class A
CENTA
$2.41B
| $535K | ﹤0.01% |
18,668
-7,747
| -29% | -$233K |
|
1790
Aaon
AAON
$7.03B
| $533K | ﹤0.01% |
10,613
+1,062
| +11% | +$49.6K |
|
|
NATI
1791
DELISTED
National Instruments Corp
NATI
| $533K | ﹤0.01% |
14,523
-40,662
| -74% | -$1.59M |
|
1792
Veracyte
VCYT
$3.73B
| $530K | ﹤0.01% |
+22,314
| New | +$519K |
|
1793
Seacoast Banking Corp of Florida
SBCF
$3.43B
| $528K | ﹤0.01% |
16,941
+2,744
| +19% | +$87.3K |
|
1794
RBC Bearings
RBC
$17.5B
| $528K | ﹤0.01% |
+2,523
| New | +$576K |
|
1795
TriCo Bancshares
TCBK
$1.83B
| $527K | ﹤0.01% |
10,339
+1,367
| +15% | +$71.3K |
|
1796
Hyatt Hotels
H
$16.3B
| $526K | ﹤0.01% |
5,909
-85,658
| -94% | -$7.87M |
|
1797
Adaptive Biotechnologies
ADPT
$4.04B
| $525K | ﹤0.01% |
70,417
+30,856
| +78% | +$240K |
|
1798
Tanger
SKT
$4.43B
| $523K | ﹤0.01% |
29,136
-8,437
| -22% | -$151K |
|
1799
Universal Logistics Holdings
ULH
$502M
| $521K | ﹤0.01% |
15,568
+8,333
| +115% | +$292K |
|
1800
Impinj
PI
$5.32B
| $520K | ﹤0.01% |
+4,761
| New | +$501K |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.